Well, then, you don't recall correctly. I had stated that at KP there was considerable debate within the firm whether or not stock options should be expensed. You replied with a link to an article about Doerr's position, stated that this was evidence that not only was I wrong, but I also was fabricating my point out of thin air. You directly attacked my credibility without any evidence. Furthermore, you were just plain wrong.
Please don't misrepresent things to that degree or back up your statements. I wasted time discussing the matter with you thinking there was some integrity in your comments.
Message 18546710
You just made it up, didn't you, that KPCB was behind options expensing.
Message 18546787
Here is the statement that you believed I was fabricating:
There are plenty of big investors who disagree with Chambers. If you know anyone over at Kleiner Perkins, ask that person how many people there think options should be expensed. You'll be surprised at the answer.
siliconinvestor.com
First of all, you misrepresented what I said, then you went further and said I was making it up. Pretty clearly, you had no idea what you were talking about.
By the way, given that you are so fond of dropping Doerr's name on this thread, you might be interested to know that while he is still the most public partner at KP, he really isn't all that active in the firm anymore. The lead guy on their biggest deals is usually Khosla. |
